Physician profile
James Dodd
NPI 1316931447
$2,617.18
in general payments reported to CMS, 2019-2025
9 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $514 · 2021: $293 · 2022: $613 · 2023: $255 · 2024: $244 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,820.11 | 2019-2024 | Grafix, Grafix Pl, Collagenase Santyl |
| Integra Lifesciences Corporation | $180.02 | 2019-2023 | Tenoglide |
| Osiris Therapeutics INC. | $140.99 | 2019 | |
| Ani Pharmaceuticals, INC. | $117.69 | 2025 | Purified Cortrophin Gel |
| Lifenet Health | $104.22 | 2024 | Theragenesis Wound Matrix |
| Depuy Synthes Sales INC. | $103.57 | 2023 | Na, Va-Lcp |
| Bioventus LLC | $72.51 | 2022 | |
| Paratek Pharmaceuticals, INC. | $60.61 | 2022 | |
| Abbott Laboratories | $17.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dodd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.